Who is sponsoring NCT01968122?

NCT01968122 is sponsored by Zhongrong Miao.

What condition does NCT01968122 study?

NCT01968122 studies Ischemic Stroke.

What drugs are being tested in NCT01968122?

Interventions: intravascular stent therapy.

What is the status of NCT01968122?

NCT01968122 is currently COMPLETED.

Last reviewed 2017-04-25 · How we verify

Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China-a Prospective Multicenter Registry Study

NCT01968122 COMPLETED

The SAMMPRIS suggested that aggressive treatment was superior to intravascular stenting in patients with severe symptomatic intracranial atherosclerotic stenosis (ICAS) due to high complication rate in patients in stenting group. However the intravascular therapy is going on because of low complication rate in considerable Chinese studies coming from several high volume stroke centers. Given to 12.2% patients failing to aggressive medical therap in the SAMMPRIS study, it is imperative to performing an multiple prospective registry study of stenting for patients with ICAS in China.

Details

Lead sponsor	Zhongrong Miao
Status	COMPLETED
Enrolment	300
Start date	2013-09
Completion	2015-12

Conditions

Ischemic Stroke

Interventions

intravascular stent therapy

Primary outcomes

the target vessel stroke event — within 30 days after stenting

Countries

China